API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/asco-gi-2024-golden-biotechs-antroquinonol-shows-significantly-prolonged-survival-in-untreated-metastatic-pancreatic-cancer-patients-302038201.html
https://www.prnewswire.com/news-releases/targeting-ras-golden-biotech-announces-positive-results-with-longer-survival-compared-with-standard-treatments-from-interim-analysis-of-phase-2-trial-for-antroquinonol-as-1st-line-treatment-for-stage-4-metastatic-pancreatic-cance-301817006.html
https://www.prnewswire.com/news-releases/covid-19-drug-duo-achievements-goldenbiotechs-new-drug-antroquinonol-hocena-trial-receives-positive-response-from-dmc-review-and-licenses-for-4-countries-301222107.html
https://www.biospectrumasia.com/news/98/17186/taiwan-announces-breakthrough-in-aml-treatment.html
https://www.biospectrumasia.com/news/26/16217/golden-biotech-receives-fda-approval-for-covid-19-drug-trial.html